Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Large And Small-Scale Bioprocessing Market Expected to Grow Between 2025 And 2029?
In recent times, the market size of both large and small-scale bioprocessing has surged dramatically. The anticipated leap is from $59.63 billion in 2024 to $67.66 billion in 2025, with a predicted compound annual growth rate (CAGR) of 13.5%. The impressive growth observed in the past years owes to several factors such as the expansion of the medical industry, the establishment of regulatory standards, advancements in technology, growth in pharmaceutical and biotechnology sectors, and heightened concerns about food safety.
Expectations are high for the large and small-scale bioprocessing market, as its size is anticipated to witness a sharp surge in the coming years. The forecast indicates that by 2029 it will escalate to a value of$108.81 billion”, representing a compound annual growth rate (CAGR) of 12.6%. The remarkable growth slated for this period can be linked to a higher healthcare spending, broadening of the biotechnology and pharmaceutical domains, advancements in technology, regulatory demands, increased knowledge about food safety, and the impact of the COVID-19 outbreak. Major developments during this forecast period are anticipated to be brought about by the adoption of cutting-edge technologies, regional expansion, contracting out sterilization services, the implementation of eco-friendly practices, the emergence of hybrid sterilization methods, and personalization of sterilization solutions.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp
What are the Fundamental Drivers and Innovations Shaping the Large And Small-Scale Bioprocessing Market?
The large and small-scale bioprocessing market is expected to flourish due to the increasing demand for biologics. Biologics are medicinal products extracted from living organisms or their parts, encompassing blood and blood components, gene therapies, vaccines, tissues, and recombinant therapeutic proteins. The surge in demand for biologics can be attributed to advancements in biotechnological approaches, a better understanding of how diseases operate, and an increased need for personalized and targeted treatments. Large-scale and small-scale bioprocessing both play a key role in the successful development and commercialization of biologics. Small-scale bioprocessing is crucial for preliminary development, optimization, and feasibility research, while large-scale bioprocessing guarantees efficient, consistent biologics production that complies with regulatory standards for commercial distribution. As an example, the U.S. National Library of Medicine reported in February 2024 that in 2023, the FDA approved 55 new drugs, which comprised 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This shows a 50% spike compared to 37 approvals in the previous year in 2022. As such, the rising demand for biologics is fueling the growth of the large and small-scale bioprocessing market.
How Is the Large And Small-Scale Bioprocessing Market Segmented?
The large and small-scale bioprocessingmarket covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters; Cell Culture Products; Filtration Assemblies; Bioreactors Accessories; Bags And Containers; Other Products
2) By Mode: In-house; Outsourced
3) By Workflow: Downstream Processing; Fermentation; Upstream Processing
4) By Scale: Industrial Scale; Small Scale
5) By Application: Biopharmaceuticals; Specialty Industrial Chemicals; Environmental Aids
Subsegments:
1) Bioreactors Or Fermenters: Single-Use Bioreactors; Stainless Steel Bioreactors; Glass Bioreactors
2) Cell Culture Products: Cell Culture Media; Sera And Supplements; Reagents
3) Filtration Assemblies: Membrane Filters; Depth Filters; Tangential Flow Filtration Systems
4) Bioreactor Accessories: Spargers; Impellers; Sensors And Probes
5) Bags And Containers: Single-Use Bags; Storage Containers; Transfer Bags
6) Other Products: Mixers; Tubing And Connectors; Sampling Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15845&type=smp
Which Regions Are Driving the Next Phase of the Large And Small-Scale Bioprocessing Market Growth?
North America was the largest region in the large and small-scale bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Trends Are Shaping the Future of the Large And Small-Scale Bioprocessing Market?
Leading firms in the bioprocessing market, both large-scale and small-scale, are coming up with inventive products such as single-use centrifuge systems to better cater to consumers with enhanced features. These single-use centrifuge systems act as disposable, pre-sterilized devices for centrifugation, exclusively designed for separating biological substances in bioprocessing. For instance, in September 2022, Thermo Fisher Scientific Inc., a biotechnology company based in the US, introduced the DynaSpin Single-Use Centrifuge system. This innovative system aims to optimize large-scale cell culture harvesting by simplifying the separation procedure, thus reducing the number of depth filtration cartridges required. It also presents advantages such as increased product yield, operational efficiency, cost-effectiveness, and adherence to sustainable practices in biologics production. The DynaSpin system facilitates a reduction in production costs and aligns with sustainability objectives by considerably diminishing material requirements and waste compared to conventional harvest systems.
View the full report here:
How Is the Large And Small-Scale Bioprocessing Market Defined and What Are Its Core Parameters?
Large and small-scale bioprocessing are essential components of the biotechnology and pharmaceutical industries that involve using living cells or their components to obtain desired products, such as pharmaceuticals, chemicals, and biofuels. Large-scale bioprocessing refers to the industrial-level production of biological products involving large bioreactors and extensive infrastructure. In contrast, Small-scale bioprocessing consists of the production of biological products on a smaller scale, often for research, development, pilot studies, or niche markets.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15845
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model